FDA Inspection 1226821 — Gergely Krivan, M.D., Ph.D.
The FDA completed an inspection of Gergely Krivan, M.D., Ph.D. on Dec 8, 2023 in Budapest. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 8, 2023
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Budapest (Hungary)
Additional details
Clinical Investigator (CI)